Publications by authors named "Yingxia Bao"

Claim this Profile
A
A host/guest assembled hyaluronic acid-based supramolecular hydrogel with NIR-steered degradation capacity for enhanced tumor therapy through programmable drug release.
Zejun Xu, Li Liu, Junkun Duan, Bei Guo, Jiayi Liu, Yingxia Bao

Carbohydr Polym· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-level bioinformatics combined with in vitro and in vivo experiments reveal the nephrotoxicity risk of isotoosendanin.
Daiyuan Liao, Rui Yi, Jieying Luo, Fulai Li, Runhe Lin, Yingxia Bao

Ecotoxicol Environ Saf· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BYS10, a novel selective RET inhibitor, exhibits potent antitumor activity in preclinical models.
Fei Qin, Yiman Chen, Jinhai Deng, Ruizhi Guo, Zhoufan Xie, Yingxia Bao

Front Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanoparticles-incorporated hydrogel microneedle for biomedical applications: Fabrication strategies, emerging trends and future prospects.
Zejun Xu, Jiaying Chi, Fei Qin, Dongyan Liu, Yecai Lai, Yingxia Bao

Asian J Pharm Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel N-indazole derivatives as phosphodiesterase 4 inhibitors for the treatment of inflammatory bowel disease.
Lei Zheng, Kun Chen, Yifan Xie, Jiaxi Huang, Chuang Xia, Ying-Xia Bao

Eur J Med Chem· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production.
Yong-Jun Chen, Zi-Tao Guo, Hai-Qiao Chen, Shi-Fan Zhang, Ying-Xia Bao

Chem Biol Interact· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP/PKG/CREB pathway.
Jia-Yi You, Xin-Wei Liu, Ying-Xia Bao, Zheng-Nan Shen, Quan Wang

Eur J Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Molecular Prodrug Amphiphile Self-Assembled AIE Dots for Cancer Theranostics.
Xing Yang, Yuan Luo, Sanpeng Li, Xiuli Xu, Yingxia Bao

Front Bioeng Biotechnol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
Xiaoguang Huang, Yingxia Bao, Shaoxuan Zhu, Xiaona Zhang, Shilong Lan

Bioorg Med Chem Lett· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
Kang Le, Ruifang Li, Suowen Xu, Xiaoqian Wu, Heqing Huang, Yingxia Bao

Arch Biochem Biophys· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
Ping Wang, Xiaoqian Wu, Yingxia Bao, Jian Fang, Sigui Zhou

Pharmazie· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitogen-activated protein kinases ERK 1/2- and p38-GATA4 pathways mediate the Ang II-induced activation of FGF2 gene in neonatal rat cardiomyocytes.
Wenjie Tang, Youzhen Wei, Kang Le, Zhi Li, Yingxia Bao

Biochem Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of endothelin converting enzyme-1 activity or expression ameliorates angiotensin II-induced myocardial hypertrophy in cultured cardiomyocytes.
Zhaohe Wang, Yingnan Cao, Xiaoyan Shen, Xianzhang Bu, Yingxia Bao

Pharmazie· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cryptotanshinone protects primary rat cortical neurons from glutamate-induced neurotoxicity via the activation of the phosphatidylinositol 3-kinase/Akt signaling pathway.
Fangyan Zhang, Wenhua Zheng, Rongbiao Pi, Zhengrong Mei, Yingxia Bao

Exp Brain Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
Yingxia Bao, Ruifang Li, Jianmin Jiang, Birong Cai, Jie Gao

Mol Cell Biochem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis